Monitor for the effective date of the IPO and subsequent filings for a business combination target. The 15-month deadline from closing creates a time-bound catalyst for deal announcement.
Executive Summary
Allarity Acquisition Corp. filed Amendment No. 3 to its S-1 registration statement for an $80 million SPAC IPO. The company is a blank-check entity formed to pursue a business combination, with a focus on life sciences and biotechnology, and is sponsored by a wholly owned subsidiary of Allarity Therapeutics (ALLR). The filing updates pricing terms and financial disclosures but does not identify a target or materially change the offering structure.
Key Facts
- Offering of 8,000,000 units at $10.00 per unit, each consisting of one Class A ordinary share and one redeemable warrant.
- Gross proceeds of $80,000,000 from the offering, plus $2,500,000 from the sale of private warrants to the sponsor.
- Sponsor ALLR Sponsor LLC (wholly owned by Allarity Therapeutics) purchased 3,833,333 founder shares for $25,000.
- Company has 15 months from closing to complete an initial business combination.
- Trust account will hold $80,800,000 ($10.10 per public share) from offering and private warrant proceeds.
- No specific business combination target has been identified.
Financial Impact
Up to $80,800,000 in trust for a business combination; sponsor invested $2,525,000 total ($25,000 for founder shares + $2,500,000 for private warrants).
Risk Factors
- No identified acquisition target; risk of liquidation if no deal within 15 months.
- Significant dilution from founder shares purchased at $0.0065 per share vs. $10.00 IPO price.
- Conflicts of interest with sponsor and Allarity Therapeutics management.
- Warrants may expire worthless if stock price does not exceed $11.50.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001493152-26-046438 |
| Exhibit: ex3-2.htm | 0001493152-26-046438 |
| Exhibit: ex10-4.htm | 0001493152-26-046438 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 17d ago | S-1/A | — | awaiting T+20 | — | — |
Oct 6, 2026 20d ago | S-1/A | — | awaiting T+20 | — | — |
Oct 2, 2026 24d ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers